Krka Logo

Krka

KRKG | LJSE

Overview

Corporate Details

ISIN(s):
SI0031102120
LEI:
549300H9RLRTRTLRUZ73
Country:
Slovenia
Address:
Šmarješka cesta 006, 8501 Novo mesto
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Krka’s basic line of business is the production and sale of prescription pharmaceuticals, non-prescription products and animal health products. The company's focus is on the development of high-quality own-brand generic pharmaceuticals, which offer added value, and are marketed under Krka's own brands. Our products are sold in over 70 countries. As part of our business strategy we have set the objective of balanced sales in five different regions: Slovenia, Central Europe, South-East Europe, East Europe, West Europe and Overseas Markets.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-04 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 130.0 KB
2025-08-04 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.2 KB
2025-08-04 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 129.6 KB
2025-08-04 08:30
Transaction in Own Shares
Pridobivanje lastnih delnic
Slovene 2.1 KB
2025-07-28 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 124.3 KB
2025-07-28 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.1 KB
2025-07-28 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 121.8 KB
2025-07-28 08:30
Transaction in Own Shares
Pridobivanje lastnih delnic
Slovene 2.0 KB
2025-07-25 08:30
Interim Report
Press release
English 150.1 KB
2025-07-25 08:30
Interim Report
H1 2025 Unaudited Interim Report of the Krka Group and Krka, d.d
English 1.1 MB
2025-07-25 08:30
Report Publication Announcement
H1 2025 Unaudited Interim Report of the Krka Group and Krka, d. d.
English 1.1 KB
2025-07-25 08:30
Earnings Release
Sporočilo za javnost
Slovene 152.5 KB
2025-07-25 08:30
Interim Report
Nerevidirano poročilo o poslovanju skupine Krka in družbe Krka v prvem polletju…
Slovene 1.0 MB
2025-07-25 08:30
Report Publication Announcement
Nerevidirano poročilo o poslovanju skupine Krka in družbe Krka v prvem polletju…
Slovene 1.2 KB
2025-07-14 08:30
Post-Annual General Meeting Information
31st AGM Resolutions
English 188.9 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ABIVAX Logo ABIVAX France ABVX
Addex Therapeutics Ltd Logo Addex Therapeutics Ltd Switzerland ADXN
AegirBio AB Logo AegirBio AB Sweden AEGIR
AGRONOMICS LIMITED Logo AGRONOMICS LIMITED Isle of Man ANIC
AIREA PLC Logo AIREA PLC United Kingdom AIEA
Alkaloid AD Logo Alkaloid AD North Macedonia ALK
Alma Yesodot Ltd. Israel KVSR
Amphastar Pharmaceuticals Inc. Logo Amphastar Pharmaceuticals Inc. United States of America AMPH
Ananda Pharma Plc United Kingdom N/A
AnGes, Inc. Logo AnGes, Inc. Japan 4563